Clinical Outcomes of Percutaneous Coronary Intervention using Bivalirudin Versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in the NHLBI Dynamic Registry

被引：0
|
作者：
Iqbal, Sohah N.
Selzer, Faith
Feit, Frederick
Glaser, Ruchira
Mulukutla, Suresh R.
Wilensky, Robert L.
Abbott, J. Dawn
Williams, David O.
Slater, James
机构：
[1] NYU, Langone Med Ctr, New York, NY USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A66 / A67
页数：2
相关论文
共 50 条
  • [1] A pooled analysis of 3 trials of Bivalirudin versus Heparin and Glycoprotein IIb/IIIa inhibitors during Percutaneous Coronary Intervention
    Kalyanasundaram, Arun
    Sartorius, Jennifer
    Scott, Thomas
    Blankenship, James C.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 79I - 80I
  • [2] Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention
    Mahmoudi, M.
    Waksman, R.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (01): : 95 - 100
  • [3] A comparison of heparin without glycoprotein IIb/IIIa inhibition versus bivalirudin in elective percutaneous coronary intervention
    Gade, Christopher L. F.
    Feldman, Dmitny N.
    Ross, Michael
    Polin, Nichole
    Bergman, Geoffrey
    Wong, S. Chiu
    Minutello, Robert M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B87 - B87
  • [4] Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors
    Abtahian, Farhad
    Waldo, Stephen
    Jang, Ik-Kyung
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (03) : 390 - 396
  • [5] Bleeding risk and outcomes of bivalirudin versus glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated heparin in elective percutaneous coronary intervention
    Steinberg, Daniel H.
    Shah, Palak
    Slottow, Tina L. Pinto
    Kinnaird, Tim
    Roy, Probal K.
    Buch, Ashesh N.
    Javaid, Aamir
    Okabe, Teruo
    Smith, Kimberly A.
    Xue, Zhenyi
    Suddath, William
    Kent, Kenneth M.
    Satler, Lowell F.
    Satler, Lowell F.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    [J]. CIRCULATION, 2007, 116 (16) : 630 - 630
  • [6] EFFICACY AND SAFETY OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMISED TRIALS
    JiangLong
    Yang, Ren-Qiang
    Fan, Ying-Li
    Zhan, Rui
    Hu, Li-Juan
    Cheng, Xiao-Shu
    [J]. HEART, 2013, 99 : E163 - E163
  • [7] Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials
    Zhu, Jianbing
    Ge, Junbo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C132 - C132
  • [8] Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)
    Kumar, Dinesh
    Dangas, George
    Mehran, Roxana
    Kirtane, Ajay
    Bertrand, Michel
    Ebrahimi, Ramin
    Guagliumi, Giulio
    Brar, Somjot
    Fahy, Martin
    Heller, Eric
    Moses, Jeffrey
    Stone, Gregg
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07): : 941 - 945
  • [9] Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
    Li, Senjie
    Lv, Dongqing
    Liu, Caihong
    Jia, Yongping
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [10] Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Uzoma N. Ibebuogu
    Oluwaseyi Bolorunduro
    Smith Giri
    Sam Dagogo-Jack
    Blake G. Smith
    Saibal Kar
    Guy L. Reed
    [J]. American Journal of Cardiovascular Drugs, 2015, 15 : 275 - 285
12345